MedTrace Logo

Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)

NCT02975050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-07-07

No results posted yet for this study

Summary

This study has the following objective:

• To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects.

The μ-Cor validation will be demonstrated at two body locations:

1. Side location (below left armpit) for study arm 1, and
2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

Conditions

  • Health Volunteer Validation Study

Interventions

OTHER

Location

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-28
Primary Completion
2017-01-19
Completion
2017-01-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975050 on ClinicalTrials.gov